Generate a tailored SOP for Dr. Ulrike Protzer. Improve your application with a focused, well-structured draft.
Professor Ulrike Protzer studies virus-host interaction, aiming to advance the understanding of molecular immunological mechanisms involved in virus control. Her work group utilizes the knowledge gained to develop new therapeutic approaches for curing chronic hepatitis B and treating secondary diseases resulting from the virus. During the COVID-19 pandemic, she focused on immune control of SARS-CoV-2 and served as an expert in national and international committees. Professor Protzer studied medicine at the universities of Erlangen, Basel, and Durban (South Africa), obtaining her doctorate from Erlangen in 1989. She underwent further training in gastroenterology and infectiology in Frankfurt and Mainz, acquiring specialist qualifications in internal medicine in 1996. From 1996 to 2000, she spent her postdoctoral period at the Center for Molecular Biology in Heidelberg, where she completed her postdoctoral teaching qualification in virology in 2000. She embarked on a course of clinical training in specialist microbiology, virology, and infection epidemiology in 2005. Between 2002 and 2007, she led a junior research group at the University of Cologne’s Center for Molecular Medicine. In late 2007, she was appointed Chair of Virology at the Technical University of Munich, where she is also the director of the Institute of Virology and the German Research Center for Environmental Health at Helmholtz Zentrum München.